Back to search

Italy· 038600033

RELISTOR*7 flaconcini SC 12 mg 0,6 ml + 7 siringhe

A medicinal product containing metilnaltrexone, registered in Italy by BAUSCH HEALTH IRELAND LIMITED, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedRELISTOR*7 flaconcini SC 12 mg 0,6 ml…ATC—REGISTER NO.038600033PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Metilnaltrexone
Manufacturer
BAUSCH HEALTH IRELAND LIMITED
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    038600033
    RELISTOR*7 flaconcini SC 12 mg 0,6 ml + 7 siringhe
    EUR 287.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Metilnaltrexone in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metilnaltrexone products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Relistor
  • Iceland · Relistor
  • Liechtenstein · Relistor
  • Norway · Relistor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/756d58f8-6b91-4d2e-b9b6-a8d9f8a4299a
GET /v1/drugs/756d58f8-6b91-4d2e-b9b6-a8d9f8a4299a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 287.25,
  "source": "aifa",
  "currency": "EUR",
  "strength": "METILNALTREXONE 12MG 7 UNITA' USO PARENTERALE",
  "substance": "Metilnaltrexone",
  "equivalence_group": "OPA",
  "transparency_flag": null
}

See everything about metilnaltrexone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.